Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Shimizu

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Digestive Diseases (Basel, Switzerland)|November 12, 2023
A Novel Hemostatic Peptide Solution for Common Acute Gastrointestinal Bleeding Diseases: First Case Series Study on the Treatment Results of Endoscopic Hemostasis by Nonexpert EndoscopistsAi Fujimoto, Tsuyoshi Ishii, Tomomi Hiraoka, et al.
Leukemia Research|October 5, 2016
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemiaRyo Shimizu, Tomoya Muto, Kazumasa Aoyama, et al.
Genome Announcements|April 5, 2014
Draft Genome Sequences of Psychrobacter Strains JCM 18900, JCM 18901, JCM 18902, and JCM 18903, Isolated Preferentially from Frozen Aquatic OrganismsToshiaki Kudo, Akihiro Kidera, Muneaki Kida, et al.
Cell Host & Microbe|June 25, 2021
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivityChihiro Motozono, Mako Toyoda, Jiri Zahradnik, et al.
Iscience|December 12, 2022
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variantIzumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Nature|February 1, 2022
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantRigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Cell Host & Microbe|January 27, 2024
Virological characteristics of the SARS-CoV-2 BA.2.86 variantTomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Nature Communications|February 8, 2024
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variantTomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
Cell|October 5, 2022
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Nature|November 25, 2021
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutationAkatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Digestive Diseases (Basel, Switzerland)|November 12, 2023
A Novel Hemostatic Peptide Solution for Common Acute Gastrointestinal Bleeding Diseases: First Case Series Study on the Treatment Results of Endoscopic Hemostasis by Nonexpert EndoscopistsAi Fujimoto, Tsuyoshi Ishii, Tomomi Hiraoka, et al.
Leukemia Research|October 5, 2016
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemiaRyo Shimizu, Tomoya Muto, Kazumasa Aoyama, et al.
Genome Announcements|April 5, 2014
Draft Genome Sequences of Psychrobacter Strains JCM 18900, JCM 18901, JCM 18902, and JCM 18903, Isolated Preferentially from Frozen Aquatic OrganismsToshiaki Kudo, Akihiro Kidera, Muneaki Kida, et al.
Cell Host & Microbe|June 25, 2021
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivityChihiro Motozono, Mako Toyoda, Jiri Zahradnik, et al.
Iscience|December 12, 2022
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variantIzumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Nature|February 1, 2022
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantRigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Cell Host & Microbe|January 27, 2024
Virological characteristics of the SARS-CoV-2 BA.2.86 variantTomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Nature Communications|February 8, 2024
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variantTomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
Cell|October 5, 2022
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Nature|November 25, 2021
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutationAkatsuki Saito, Takashi Irie, Rigel Suzuki, et al.
Pageof 12